|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Outlook Therapeutics (NASDAQ: OTLK) through any online brokerage.
The latest price target for Outlook Therapeutics (NASDAQ: OTLK) was reported by HC Wainwright & Co. on 2020-08-27. The analyst firm set a price target for 5.00 expecting OTLK to rise to within 12 months (a possible 130.41% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Outlook Therapeutics (NASDAQ: OTLK) is $2.17 last updated Fri May 07 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Outlook Therapeutics.
There is no upcoming split for Outlook Therapeutics.